Evidence map›Paper›PMID 40718150›Full record

ArticleHealth equity2025

COVID-19 Vaccine Rollout Strategies in Utah from Local Health Departments' Perspectives: A Qualitative Analysis of Focus Group Discussions.

Khanh N C Duong, Sajesh K Veettil, Richard E Nelson, Barbara E Jones, Andrew T Pavia, Danielle T Nguyen, Makoto M Jones, Matthew H Samore, Susan L Zickmund, Patrick Galyean and 1 more

Abstract read
In one paragraph

Article in Health equity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Khanh N C DuongDepartment of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, Utah, USA.
Sajesh K VeettilDepartment of Pharmacy Practice, School of Pharmacy, IMU University, Kuala Lumpur, Malaysia.
Richard E NelsonIDEAS Center, Veterans Affairs Salt Lake City Health Care System, Salt Lake City, Utah, USA.
Barbara E JonesIDEAS Center, Veterans Affairs Salt Lake City Health Care System, Salt Lake City, Utah, USA.
Andrew T PaviaDivision of Pediatric Infectious Diseases, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, Utah, USA.
Danielle T NguyenDepartment of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, Utah, USA.
Makoto M JonesIDEAS Center, Veterans Affairs Salt Lake City Health Care System, Salt Lake City, Utah, USA.
Matthew H SamoreIDEAS Center, Veterans Affairs Salt Lake City Health Care System, Salt Lake City, Utah, USA.
Susan L ZickmundIDEAS Center, Veterans Affairs Salt Lake City Health Care System, Salt Lake City, Utah, USA.
Patrick GalyeanDivision of Epidemiology, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, Utah, USA.
Nathorn ChaiyakunaprukDepartment of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, Utah, USA.ORCID https://orcid.org/0000-0003-4572-8794

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Local health departments (LHDs) play an essential role in providing COVID-19 vaccines to underserved populations in Utah. This study aimed to understand barriers to COVID-19 vaccine uptake for these populations and challenges faced by LHDs from LHDs' perspectives. In addition, we explored LHDs' experience with implementing COVID-19 mobile vaccine clinics (MVCs) in Utah. Materials and Methods: We conducted virtual focus group discussions (FGDs) from October 28 to November 1, 2022, with health officers from Utah's Department of Health and Human Services (DHHS) and LHDs. We recruited participants via email, transcribed recordings verbatim, and analyzed data using inductive content analysis. Results: Eight participants, one from the Utah DHHS and seven from Utah's LHDs (mostly executive directors or managers), participated in two FGDs. Barriers to vaccine uptake among underserved communities included structural, behavioral, and informational barriers. LHDs faced two main challenges to increasing vaccination rate: limited resources and the lack of established partnerships with trusted communities/organizations/leaders. Strategies implemented to increase vaccine uptake included multiple channels for vaccine access and information provision, and building multiple partnerships. Key lessons learned were the importance of partnerships with trusted community/organization leaders and building core staff for vaccine uptake. Regarding MVCs, they were effective in reaching underserved populations, however, their impact was unclear in rural areas. Conclusion: Building trust through partnerships with trusted community/organization leaders was crucial for increasing vaccine uptake in underserved populations and promoting health equity. The impact of MVCs on underserved populations in different settings remains unclear, further research is needed.

Indexed as

COVID-19 vaccine strategiesfocus group discussionshealth equitylocal health departmentsmobile vaccine clinicsUtah

Identifiers

PMID40718150
PMCPMC12290390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.